Search research articles
Contact Us
Filters
Showing results (1-10 of 60) with videos related to
Page
of 6
Sort By:
Cancers
|
June 3, 2015
Quality of Life in Patients with NSCLC Receiving Maintenance Therapy
Achim Rittmeyer
Deutsches Arzteblatt International
|
November 14, 2013
Smoking cessation in lung cancer-achievable and effective
Stefan Andreas, Achim Rittmeyer, Marc Hinterthaner, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
July 15, 2021
Update on recent key publications in lung oncology: picking up speed
Achim Rittmeyer, Annett Schiwitza, Lejla Sahovic, et al.
BMC Pulmonary Medicine
|
June 27, 2022
Smoking cessation by combined medication and counselling: a feasibility study in lung cancer patients
Christian Reinhardt, Markus Harden, Christoph Herrmann-Lingen, et al.
Expert Opinion on Biological Therapy
|
March 25, 2017
Prospects and progress of atezolizumab in non-small cell lung cancer
Johan Vansteenkiste, Els Wauters, Keunchil Park, et al.
Cancer Immunology, Immunotherapy : CII
|
April 6, 2026
Correction: Comparison of real-world efficacy and safety of nivolumab plus ipilimumab or pembrolizumab combined with platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer in a German population
Moritz Weber, Alexander Freiherr von Hammerstein-Equord, Manuela Weinreich, et al.
Immunotherapy
|
December 13, 2019
Abscopal effect in lung cancer: three case reports and a concise review
Elena Garelli, Achim Rittmeyer, Paul Martin Putora, et al.
Cancer Immunology, Immunotherapy : CII
|
January 31, 2026
Comparison of real-world efficacy and safety of nivolumab plus ipilimumab or pembrolizumab combined with platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer in a German population
Moritz Weber, Alexander Freiherr von Hammerstein-Equord, Manuela Weinreich, et al.
Journal of Geriatric Oncology
|
October 8, 2018
Multidisciplinary treatment of lung cancer in older patients: A review
Marco Radovic, Ravindran Kanesvaran, Achim Rittmeyer, et al.
ERJ Open Research
|
September 23, 2020
Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy
Thomas Iseli, Thierry Berghmans, Markus Glatzer, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 60) with videos related to
Sort By:
Page
of 6
Cancers
|
June 3, 2015
Quality of Life in Patients with NSCLC Receiving Maintenance Therapy
Achim Rittmeyer
Deutsches Arzteblatt International
|
November 14, 2013
Smoking cessation in lung cancer-achievable and effective
Stefan Andreas, Achim Rittmeyer, Marc Hinterthaner, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
July 15, 2021
Update on recent key publications in lung oncology: picking up speed
Achim Rittmeyer, Annett Schiwitza, Lejla Sahovic, et al.
BMC Pulmonary Medicine
|
June 27, 2022
Smoking cessation by combined medication and counselling: a feasibility study in lung cancer patients
Christian Reinhardt, Markus Harden, Christoph Herrmann-Lingen, et al.
Expert Opinion on Biological Therapy
|
March 25, 2017
Prospects and progress of atezolizumab in non-small cell lung cancer
Johan Vansteenkiste, Els Wauters, Keunchil Park, et al.
Cancer Immunology, Immunotherapy : CII
|
April 6, 2026
Correction: Comparison of real-world efficacy and safety of nivolumab plus ipilimumab or pembrolizumab combined with platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer in a German population
Moritz Weber, Alexander Freiherr von Hammerstein-Equord, Manuela Weinreich, et al.
Immunotherapy
|
December 13, 2019
Abscopal effect in lung cancer: three case reports and a concise review
Elena Garelli, Achim Rittmeyer, Paul Martin Putora, et al.
Cancer Immunology, Immunotherapy : CII
|
January 31, 2026
Comparison of real-world efficacy and safety of nivolumab plus ipilimumab or pembrolizumab combined with platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer in a German population
Moritz Weber, Alexander Freiherr von Hammerstein-Equord, Manuela Weinreich, et al.
Journal of Geriatric Oncology
|
October 8, 2018
Multidisciplinary treatment of lung cancer in older patients: A review
Marco Radovic, Ravindran Kanesvaran, Achim Rittmeyer, et al.
ERJ Open Research
|
September 23, 2020
Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy
Thomas Iseli, Thierry Berghmans, Markus Glatzer, et al.
Page
of 6